Abstract:ABSTRACT Ciprofloxacin-resistant Salmonella Typhimurium ( S. Typhimurium) causes a significant health burden worldwide. A wealth of studies has been published on the contributions of different mechanisms to ciprofloxacin resistance in Salmonella spp. But we still lack a deep understanding of the physiological responses and genetic changes that underlie ciprofloxacin exposure. This study aims to know how phenotypic and genotypic characteristics are impacted by ciprofloxacin exposure, from ciprofloxacin-susceptible to ciprofloxacin-resistant strains in vitro . Here, we investigated the multistep evolution of resistance in replicate populations of S. Typhimurium during 24 days of continuously increasing ciprofloxacin exposure and assessed how ciprofloxacin impacts physiology and genetics. Numerous studies have demonstrated that RamA is a global transcriptional regulator that prominently perturbs the transcriptional landscape of S. Typhimurium, resulting in a ciprofloxacin-resistant phenotype appearing first; the quinolone resistance-determining region mutation site can only be detected later. Comparing the microbial physiological changes and RNA sequencing (RNA-Seq) results of ancestral and selectable mutant strains, the selectable mutant strains had some fitness costs, such as decreased virulence, an increase of biofilm-forming ability, a change of “collateral” sensitivity to other drugs, and inability to utilize galactitol. Importantly, in the ciprofloxacin induced, RamA directly binds and activates the gatR gene responsible for the utilization of galactitol, but RamA deletion strains could not activate gatR . The elevated levels of RamA, which inhibit the galactitol metabolic pathway through the activation of gatR , can lead to a reduction in the growth rate, adhesion, and colonization resistance of S . Typhimurium. This finding is supported by studies conducted in M9 medium as well as in vivo infection models. IMPORTANCE Treatment of antibiotic resistance can significantly benefit from a deeper understanding of the interactions between drugs and genetics. The physiological responses and genetic mechanisms in antibiotic-exposed bacteria are not well understood. Traditional resistance studies, often retrospective, fail to capture the entire resistance development process and typically exhibit unpredictable dynamics. To explore how clinical isolates of S. Typhimurium respond to ciprofloxacin, we analyzed their adaptive responses. We found that S. Typhimurium RamA-mediated regulation disrupts microbial metabolism under ciprofloxacin exposure, affecting genes in the galactitol metabolic pathways. This disruption facilitates adaptive responses to drug therapy and enhances the efficiency of intracellular survival. A more comprehensive and integrated understanding of these physiological and genetic changes is crucial for improving treatment outcomes.

TisB protein is the single molecular determinant underlying multiple downstream effects of ofloxacin in Escherichia coli

Multi-omics analysis explores the impact of ofloxacin pressure on the metabolic state in Escherichia coli

Impact of suppression of the SOS response on protein expression in clinical isolates of Escherichia coli under antimicrobial pressure of ciprofloxacin

Suppression of bacterial cell death underlies the antagonistic interaction between ciprofloxacin and tetracycline in

Synergistic Quinolone Sensitization by Targeting the recA SOS Response Gene and Oxidative Stress

Transcriptomic and proteomic analysis of the virulence inducing effect of ciprofloxacin on enterohemorrhagic Escherichia coli

Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance

Vibrio alginolyticus Survives From Ofloxacin Stress by Metabolic Adjustment

Bactericidal effect of tetracycline in E. coli strain ED1a may be associated with ribosome dysfunction

Metabolic and transcriptional activities underlie stationary-phase Pseudomonas aeruginosa sensitivity to Levofloxacin

Identification of Novel Genes Involved in Escherichia coli Persistence to Tosufloxacin

Oxidation of dCTP contributes to antibiotic lethality in stationary-phase mycobacteria.

ATP burst is the dominant driver of antibiotic lethality in Mycobacterium smegmatis

Elucidating TolC Protein Dynamics: Structural Shifts Facilitate Efflux Mediated β-lactam Resistance

Genetic and in-silico approaches for investigating the mechanisms of ciprofloxacin resistance in Salmonella typhi: Mutations, extrusion, and antimicrobial resistance

Cytoplasmic condensation induced by membrane damage is associated with antibiotic lethality

Salmonella Typhimurium alters galactitol metabolism under ciprofloxacin treatment to balance resistance and virulence

Identification of Determinants that Allow Maintenance of High-Level Fluoroquinolone Resistance in

The intracellular concentrations of fluoroquinolones determined the antibiotic resistance response of Escherichia coli

Bactericidal activities and post-antibiotic effects of ofloxacin and ceftriaxone against drug-resistant Salmonella enterica serovar Typhi

Target-Mediated Fluoroquinolone Resistance in Neisseria gonorrhoeae : Actions of Ciprofloxacin against Gyrase and Topoisomerase IV